SCHEMBL8187613

SCHEMBL8187613

CCCC[Sn](CCCC)(CCCC)c1ccc([C]=O)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1983658 0.83 TSHR (0.32)
SCHEMBL1453582 0.81 TSHR (0.46)
SCHEMBL17095072 0.79
SCHEMBL15648671 0.77 BDKRB2 (0.36)
SCHEMBL15648819 0.77 BDKRB2 (0.36)
SCHEMBL1452840 0.75 HTT (0.38)
SCHEMBL2721463 0.74 CYP1A2 (0.39)
SCHEMBL154543 0.74 TP53 (0.37)
SCHEMBL1096789 0.74 HTR7 (0.41)
SCHEMBL5787759 0.74 MAPT (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6083926-A AGENT COMPRISED OF VITAMIN B12 COVALENTLY COUPLED TO BIOTIN BY WATER-SOLUBLE LINKER THE UNIVERSITY OF WASHINGTON (US) 2000-07-04 US disclosed
US-5869465-A BINDING TO CELL SURFACE RECEPTORS AND AFFECTING THEIR TRAFFICKING PATHWAY FOR THE TREATMENT AND DIAGNOSIS OF DISORDERS IN WARM-BLOODED ANIMALS RECEPTAGEN CORPORATION (US) 1999-02-09 US disclosed
US-5840712-A TARGETS AND LINKERS RECEPTAGEN CORPORATION (US) 1998-11-24 US disclosed
US-5739287-A BOUND ALSO TO A RECEPTOR MODULATING AGENT TO IMPEDE CELL SURFACE RECEPTOR TRAFFICKING PATHWAYS BY INHIBITING THE RECYCLING OF RECEPTORS TO THE CELL SURFACE; ANTITUMOR AND -CARCINOGENIC AGENTS; LEUKEMIA UNIVERSITY OF WASHINGTON (US) 1998-04-14 US disclosed